BSD Medical's Stellar Performance

BSD Medical Corp. (BSDM) up 79 cents to 3.94, a nice percentage gain today. The stock did so well it made Harry Boxer's Chart of the Day on The Technical Trader. View the Chart Here.

Wikinvest---BSD Medical Corporation (NASDAQ:BSDM) went up 25.08% to $3.94 on over 3.07 million shares. BSD Medical Corporation develops, manufactures, markets and services medical systems that deliver precision-focused radio frequency (RF) or microwave energy into diseased sites of the body, heating them to specified temperatures as required by a variety of medical therapies.

So far, the market capitalization of the stock stands at $103.14 million and average daily volume of the stock is 1.29 million shares. Today, the stock made its fresh 52-week high of $4.08.

September 29, 2010

BSD Medical Obtains Patent on Innovative Design for Heat Therapy Devices

BSD Medical's Stock is Rising Fast: BSDM

BSD Medical is going up like hotcakes these days. I still think there is plenty of room for future growth. Today's trading is BSDM 3.16 +0.19 (6.40%) They recently had FDA approval for cancer treatment medical device. I don't think it's too late to get on board with this stock and see it as a real Long Term Growth Potential. They are selling their newly acquired 510K approved products at a rapid pace to Cancer Treatment centers across the country.

Wikinvest is a great Market Tool: BSD Medical




Texas Oncology Acquires Hyperthermia System from BSD Medical

BSD Medical receives FDA clearance for MTX-180

Image via CrunchBase SALT LAKE CITY, Aug 18, 2010 (BUSINESS WIRE) -- BSD Medical Corporation /quotes/comstock/15*!bsdm/quotes/nls/bsdm (BSDM 1.82, +0.69, +61.06%) (Company or BSD) today announced that the U.S. Food and Drug Administration (FDA) has granted the Company a 510(k) clearance to market its MicroThermX Microwave Ablation System (MTX-180) for ablation of soft tissue. Clearance from the FDA of BSD's 510(k) Premarket Notification submission authorizes the commercial sale of the MTX-180 in the United States. The MTX-180 was designed to provide a higher power, optimized system targeted to the growing therapeutic interventional and surgical oncology market.